Skip to main content

3D Predict

ApplicationNew York, New York, USAFounded 2014· One of 313 Application companies tracked by AMPulse

An AI-powered clear dental aligner system that creates highly predictable treatment plans by using 3D analysis of the patient's teeth, including the roots and bone from CBCT scans.

CEO / Founder
Dr. Marina Domracheva
Team Size
11-50
Stage
Active
Total Funding
$5.3M
Latest Round
Venture Round
Key Investors
XTX Ventures, One Way Ventures, Davidovs Venture Collective, Go Global World

Technology & Products

Key Products

AI-driven dental aligners with root and bone analysis technology

Technological Advantage

This comprehensive 3D analysis prevents anatomically impossible tooth movements, leading to more effective and efficient treatment plans. This results in a significant reduction in treatment time and fewer refinements, providing a competitive edge over traditional aligners that only model the visible tooth crowns.

Differentiation

Value Proposition

To provide a more predictable, efficient, and faster clear aligner treatment by using AI to analyze the entire tooth and bone structure, reducing treatment time by up to 30% and minimizing the need for mid-course corrections.

How They Differentiate

3D Predict differentiates itself by its foundational technology of analyzing the entire tooth structure, including roots and bone, with its AI-powered software. This contrasts with major competitors like Invisalign, which traditionally focus on the visible crowns, giving 3D Predict an advantage in predictability and the ability to treat more complex cases.

Market & Competition

Target Customers

Orthodontists and dental professionals

Industry Verticals

["Dental","Orthodontics"]

Competitors

Align Technology (Invisalign); Candid; Byte

Growth & Milestones

Growth Metrics

The company has successfully treated thousands of patients and has expanded its operations across the US, Europe, and Asia. It has also secured multiple funding rounds.

Major Milestones

["Founded in 2014","Patented its core technology in 2017","Received FDA clearance in February 2020","Launched in the U.S. market in 2020","Selected for Google's Startup Program","Closed a Series A funding round in March 2021"]